Literature DB >> 23485372

Expression of heterologous proteins flanked by NS3-4A cleavage sites within the hepatitis C virus polyprotein.

Joshua A Horwitz1, Marcus Dorner, Tamar Friling, Bridget M Donovan, Alexander Vogt, Joana Loureiro, Thomas Oh, Charles M Rice, Alexander Ploss.   

Abstract

Hepatitis C virus (HCV) contributes substantially to human morbidity and mortality world-wide. The development of HCV genomes expressing heterologous proteins has enhanced the ability to study viral infection, but existing systems have drawbacks. Recombinant viruses often require adaptive mutations to compensate for reduced viral titers, or rely on an artificial genomic organization that uncouples viral protein expression from recombinant gene expression. Here, we sought to exploit the viral polyprotein processing machinery to express heterologous proteins within the context of the HCV polyprotein. We show that HCV genotypes 2a and 1b permit insertion of reporter proteins between NS5A and NS5B with minimal impact on viral fitness. Using this strategy we constructed reporter genomes exhibiting a wide dynamic range, simplifying analysis of HCV infection in primary hepatocytes. Expression of heterologous proteins within the HCV genome offers new opportunities to analyze HCV infection in experimental systems without perturbing functions of individual viral proteins.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23485372      PMCID: PMC3620014          DOI: 10.1016/j.virol.2013.01.019

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  43 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures.

Authors:  Svetlana Marukian; Linda Andrus; Timothy P Sheahan; Christopher T Jones; Edgar D Charles; Alexander Ploss; Charles M Rice; Lynn B Dustin
Journal:  Hepatology       Date:  2011-12       Impact factor: 17.425

3.  Establishment of a novel permissive cell line for the propagation of hepatitis C virus by expression of microRNA miR122.

Authors:  Hiroto Kambara; Takasuke Fukuhara; Mai Shiokawa; Chikako Ono; Yuri Ohara; Wataru Kamitani; Yoshiharu Matsuura
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

4.  Reconstitution of the entire hepatitis C virus life cycle in nonhepatic cells.

Authors:  Daniel Da Costa; Marine Turek; Daniel J Felmlee; Erika Girardi; Sébastien Pfeffer; Gang Long; Ralf Bartenschlager; Mirjam B Zeisel; Thomas F Baumert
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

Review 5.  Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus.

Authors:  K Morikawa; C M Lange; J Gouttenoire; E Meylan; V Brass; F Penin; D Moradpour
Journal:  J Viral Hepat       Date:  2011-03-23       Impact factor: 3.728

6.  Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.

Authors:  Haizhen Zhu; Huijia Dong; Erika Eksioglu; Alan Hemming; Mengde Cao; James M Crawford; David R Nelson; Chen Liu
Journal:  Gastroenterology       Date:  2007-09-16       Impact factor: 22.682

7.  Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.

Authors:  Judith M Gottwein; Troels K H Scheel; Tanja B Jensen; Jacob B Lademann; Jannick C Prentoe; Maria L Knudsen; Anne M Hoegh; Jens Bukh
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

8.  Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.

Authors:  H Nakabayashi; K Taketa; K Miyano; T Yamane; J Sato
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

9.  Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells.

Authors:  MinKyung Yi; Rodrigo A Villanueva; David L Thomas; Takaji Wakita; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

10.  Complete replication of hepatitis C virus in cell culture.

Authors:  Brett D Lindenbach; Matthew J Evans; Andrew J Syder; Benno Wölk; Timothy L Tellinghuisen; Christopher C Liu; Toshiaki Maruyama; Richard O Hynes; Dennis R Burton; Jane A McKeating; Charles M Rice
Journal:  Science       Date:  2005-06-09       Impact factor: 47.728

View more
  13 in total

1.  Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice.

Authors:  Margaret A Scull; Chao Shi; Ype P de Jong; Gisa Gerold; Moritz Ries; Markus von Schaewen; Bridget M Donovan; Rachael N Labitt; Joshua A Horwitz; Jenna M Gaska; Gabriela Hrebikova; Jing W Xiao; Brenna Flatley; Canny Fung; Luis Chiriboga; Christopher M Walker; David T Evans; Charles M Rice; Alexander Ploss
Journal:  Hepatology       Date:  2015-04-15       Impact factor: 17.425

2.  Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells.

Authors:  Raphael Wolfisberg; Kenn Holmbeck; Louise Nielsen; Amit Kapoor; Charles M Rice; Jens Bukh; Troels K H Scheel
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

3.  Multifaceted activities of type I interferon are revealed by a receptor antagonist.

Authors:  Doron Levin; William M Schneider; Hans-Heinrich Hoffmann; Ganit Yarden; Alberto Giovanni Busetto; Ohad Manor; Nanaocha Sharma; Charles M Rice; Gideon Schreiber
Journal:  Sci Signal       Date:  2014-05-27       Impact factor: 8.192

4.  Production and characterization of high-titer serum-free cell culture grown hepatitis C virus particles of genotype 1-6.

Authors:  Christian K Mathiesen; Tanja B Jensen; Jannick Prentoe; Henrik Krarup; Alfredo Nicosia; Mansun Law; Jens Bukh; Judith M Gottwein
Journal:  Virology       Date:  2014-05-24       Impact factor: 3.616

5.  Polymorphisms in melanoma differentiation-associated gene 5 link protein function to clearance of hepatitis C virus.

Authors:  Franziska S Hoffmann; Andreas Schmidt; Meike Dittmann Chevillotte; Christian Wisskirchen; Johannes Hellmuth; Simone Willms; Rachel H Gilmore; Jürgen Glas; Matthias Folwaczny; Tobias Müller; Thomas Berg; Ulrich Spengler; Karen Fitzmaurice; Dermot Kelleher; Nicole Reisch; Charles M Rice; Stefan Endres; Simon Rothenfusser
Journal:  Hepatology       Date:  2015-01-05       Impact factor: 17.425

6.  Hepatitis C virus RNA functionally sequesters miR-122.

Authors:  Joseph M Luna; Troels K H Scheel; Tal Danino; Katharina S Shaw; Aldo Mele; John J Fak; Eiko Nishiuchi; Constantin N Takacs; Maria Teresa Catanese; Ype P de Jong; Ira M Jacobson; Charles M Rice; Robert B Darnell
Journal:  Cell       Date:  2015-03-12       Impact factor: 41.582

7.  Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines.

Authors:  Alexander Vogt; Margaret A Scull; Tamar Friling; Joshua A Horwitz; Bridget M Donovan; Marcus Dorner; Gisa Gerold; Rachael N Labitt; Charles M Rice; Alexander Ploss
Journal:  Virology       Date:  2013-06-16       Impact factor: 3.616

8.  Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmission.

Authors:  Maria Teresa Catanese; Joana Loureiro; Christopher T Jones; Marcus Dorner; Thomas von Hahn; Charles M Rice
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

9.  Evasion of superinfection exclusion and elimination of primary viral RNA by an adapted strain of hepatitis C virus.

Authors:  Brian Webster; Melanie Ott; Warner C Greene
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

Review 10.  Visualizing hepatitis C virus infection in humanized mice.

Authors:  Markus von Schaewen; Qiang Ding; Alexander Ploss
Journal:  J Immunol Methods       Date:  2014-03-15       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.